NECTAR LIFESCIENCES
Back to Cashflow Statement
|
NECTAR LIFESCIENCES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹169 Cr | ₹225 Cr | ₹134 Cr | ₹95 Cr | ₹21 Cr |
What is the latest Cash Flow from Operating Activities ratio of NECTAR LIFESCIENCES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹169 Cr |
| Mar2024 | ₹225 Cr |
| Mar2023 | ₹134 Cr |
| Mar2022 | ₹95 Cr |
| Mar2021 | ₹21 Cr |
How is Cash Flow from Operating Activities of NECTAR LIFESCIENCES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹169 Cr | -24.59 | |
| Mar2024 | ₹225 Cr | 68.11 | |
| Mar2023 | ₹134 Cr | 40.68 | |
| Mar2022 | ₹95 Cr | 344.38 | |
| Mar2021 | ₹21 Cr | - | |
Compare Cash Flow from Operating Activities of peers of NECTAR LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NECTAR LIFESCIENCES | ₹213.9 Cr | -1.7% | -18.6% | -61.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,693.0 Cr | -0.4% | 5.3% | 13.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,270.0 Cr | -4.3% | -6.3% | 12.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,281.0 Cr | 0.4% | 8.2% | 44.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,422.0 Cr | 0.5% | 1.8% | 16.4% | Stock Analytics | |
| CIPLA | ₹104,915.0 Cr | -0.8% | -2.6% | -9.2% | Stock Analytics | |
NECTAR LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NECTAR LIFESCIENCES | -1.7% |
-18.6% |
-61.1% |
| SENSEX | -2.7% |
-10.4% |
1.6% |
You may also like the below Video Courses